The company must navigate several challenges in order for its leukemia drug Iclusig to become a blockbuster.
US markets are set to start the session unchanged as investors digest some key earnings results and await consumer sentiment data.
Indication that Europe is improving could not offset the negative sentiment ahead of more earnings and economic data.
These companies offer long-term growth and immediate income.
This year has been a little too good for Kellogg and a few others.
This sector has been back in vogue, but investors could miss out on further upside without careful stock selection.
Stocks are mixed as the Dow and S&P 500 have gained, but the tech-heavy Nasdaq is lagging.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
With the universe of this category in its seasonal sweet spot, these picks have tailwinds propelling them into the new year.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.